Candriam Luxembourg S.C.A. decreased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 27.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,265 shares of the exchange traded fund’s stock after selling 865 shares during the quarter. Candriam Luxembourg S.C.A.’s holdings in SPDR S&P Biotech ETF were worth $254,000 as of its most recent filing with the SEC.

Several other large investors have also added to or reduced their stakes in XBI. JPMorgan Chase & Co. lifted its stake in shares of SPDR S&P Biotech ETF by 9,599.3% in the first quarter. JPMorgan Chase & Co. now owns 9,853,687 shares of the exchange traded fund’s stock worth $763,069,000 after acquiring an additional 9,752,095 shares in the last quarter. Morgan Stanley lifted its stake in shares of SPDR S&P Biotech ETF by 18.2% in the first quarter. Morgan Stanley now owns 9,002,902 shares of the exchange traded fund’s stock worth $697,184,000 after acquiring an additional 1,387,956 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of SPDR S&P Biotech ETF in the first quarter worth about $38,742,000. tru Independence LLC lifted its stake in shares of SPDR S&P Biotech ETF by 234.6% in the first quarter. tru Independence LLC now owns 378,743 shares of the exchange traded fund’s stock worth $21,475,000 after acquiring an additional 265,559 shares in the last quarter. Finally, Meitav Dash Investments Ltd. lifted its stake in shares of SPDR S&P Biotech ETF by 6,965.4% in the first quarter. Meitav Dash Investments Ltd. now owns 228,567 shares of the exchange traded fund’s stock worth $17,700,000 after acquiring an additional 225,332 shares in the last quarter.

NYSEARCA:XBI opened at $109.33 on Friday. The business’s 50-day simple moving average is $111.77 and its 200 day simple moving average is $96.63. SPDR S&P Biotech ETF has a one year low of $62.94 and a one year high of $121.06.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More: What is the return on assets (ROA) ratio?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.